# NATIONAL MEDICAL SERVICES:1106803 [21-003850]

> **NIH NIH N02** · NATIONAL MEDICAL SERVICES, INC. · 2021 · $150,000

## Abstract

This purpose of this contract is to procure sequencing reagents to perform large-scale, high throughput whole genome sequencing of post-mortem human brain samples in the NIH NeuroBioBank inventory. The reagents are chemicals and enzymes used in genome sequencing methodologies. The project goal is to characterize tissues at the DNA level, thereby creating a shared data resource for the neuroscience and mental health research community.

## Key facts

- **NIH application ID:** 10505245
- **Project number:** 75N95020D00002-0-759502100002-1
- **Recipient organization:** NATIONAL MEDICAL SERVICES, INC.
- **Principal Investigator:** THOMAS MEAKER
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $150,000
- **Award type:** —
- **Project period:** 2020-01-01 → 2023-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10505245

## Citation

> US National Institutes of Health, RePORTER application 10505245, NATIONAL MEDICAL SERVICES:1106803 [21-003850] (75N95020D00002-0-759502100002-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10505245. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*